Title : Investigational Janus kinase inhibitors in development for myelofibrosis.

Pub. Date : 2017 Jun

PMID : 28441920






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 If approved, the JAK2-specific non-myelosuppressive inhibitor pacritinib could fulfill a major unmet need, that of patients with significant cytopenias. 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene Janus kinase 2 Homo sapiens